Leash Bio warns of ‘cheating’ AI models on drug-protein predictions

A small crew of scientists in Utah is warning of a thorny problem for the AI bio field. Leash Bio CEO Ian Quigley told Endpoints News he believes many of today’s cutting-edge AI models are …
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks